Roche supports cancer care development program in Ethiopia
23 January 2012 | By Roche
Establishment of a program to improve basic cancer care in Ethiopia...
List view / Grid view
News
Novartis drug Signifor® recommended by CHMP
20 January 2012 | By Novartis
If approved, Signifor would be the first approved medication targeting Cushing's disease...
FDA updates TYSABRI(R) (NATALIZUMAB) label to include anti-JCV antibody status as a PML risk factor
20 January 2012 | By Biogen Idec and Elan Corporation, plc
The U.S. FDA has approved a product label change for TYSABRI...
CHMP recommends EU approval to update Novartis drug Glivec® label to include three year treatment for GIST patients after surgery
20 January 2012 | By Novartis
Update of the Glivec® (imatinib)* label...
Merck resolves Vioxx® litigation in Canada
19 January 2012 | By Merck
Merck announced that it has entered into an agreement to resolve all claims related to Vioxx® in Canada...
Bristol-Myers Squibb announces charitable donation of $6.9 million to support cancer patients
19 January 2012 | By Bristol-Myers Squibb Company
Donation of $6.9 million in 2011 to support the HealthWell Foundation...
B&W Tek to introduce spectral data acquisition software at SPIE’s BiOS & Photonics West Exhibits
19 January 2012 | By B&W Tek
B&W Tek, Inc., is proud to introduce BWSpec™ 4.00...
Patheon adds soft gel capsule capabilities through new partnership with Procaps, S.A.
19 January 2012 | By Acquire Media
Patheon and PROCAPS S.A. are pleased to announce an agreement to provide the pharmaceutical industry a new world-class line of prescription pharmaceutical soft-gel product development and manufacturing services...
Sandoz initiates two more Phase III biosimilar trials, reinforcing long-term global leadership commitment
19 January 2012 | By Novartis
Sandoz announced that it has initiated two milestone Phase III clinical trials...
AstraZeneca and Bristol-Myers Squibb receive complete response letter from US FDA for dapagliflozin
19 January 2012 | By AstraZeneca
The FDA has issued a complete response letter regarding dapagliflozin...
Abbott’s STARLIMS LIMS technology to be installed in FDA testing laboratories
18 January 2012 | By Abbott
The U.S. FDA will begin implementing Abbott’s STARLIMS® software-based laboratory information management system...
U.S. Food and Drug Administration approves new formulations of Viread® for use by children living with HIV
18 January 2012 | By Gilead Sciences Inc
Gilead Sciences, Inc. announced that the U.S. FDA has approved Viread®...
Brazil Introduces Inactivated Polio Vaccine in National Immunization Program with Sanofi Pasteur Vaccine
18 January 2012 | By Sanofi Pasteur
Brazil has chosen to introduce injectable polio vaccine in its national immunization program...
Roy D. Baynes, MD, PhD, to join Gilead Sciences as Senior Vice President, Oncology Therapeutics
18 January 2012 | By Gilead Sciences
Gilead Sciences, Inc. announced that Roy D. Baynes, MD, PhD, will join the company...
First Hepatitis C treatment data demonstrating proof of principle with direct-acting antiviral-only therapy published
18 January 2012 | By Bristol-Myers Squibb Company
Full results from a Phase II clinical trial...
